During the recent session, T2 Biosystems Inc (NASDAQ:TTOO)’s traded shares were 0.8 million, with the beta value of the company hitting 0.36. At the last check today, the stock’s price was $0.40, reflecting an intraday loss of -11.67% or -$0.05. The 52-week high for the TTOO share is $8.38, that puts it down -1995.0 from that peak though still a striking -5.0% loss since the share price plummeted to a 52-week low of $0.42. The company’s market capitalization is $8.36M, and the average intraday trading volume over the past 10 days was 0.9 million shares, and the average trade volume was 708.89K shares over the past three months.
T2 Biosystems Inc (NASDAQ:TTOO) trade information
T2 Biosystems Inc (TTOO) registered a -11.67% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -11.67% in intraday trading to $0.40, hitting a weekly high. The stock’s 5-day price performance is -22.08%, and it has moved by -27.48% in 30 days. Based on these gigs, the overall price performance for the year is -89.14%. The short interest in T2 Biosystems Inc (NASDAQ:TTOO) is 0.83 million shares and it means that shorts have 1.26 day(s) to cover.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The consensus price target of analysts on Wall Street is $5, which implies an increase of 92.0% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $5 and $5 respectively. As a result, TTOO is trading at a discount of -1150.0% off the target high and -1150.0% off the low. An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 68.62%.
TTOO Dividends
T2 Biosystems Inc is due to release its next quarterly earnings in January. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
T2 Biosystems Inc (NASDAQ:TTOO)’s Major holders
T2 Biosystems Inc insiders own 10.17% of total outstanding shares while institutional holders control 73.51%, with the float percentage being 81.83%.
